Assessment of inhaled corticosteroid treatment response in asthma using hypertonic histamine challenge-induced cough
- PMID: 20565479
- DOI: 10.1111/j.1752-699X.2009.00146.x
Assessment of inhaled corticosteroid treatment response in asthma using hypertonic histamine challenge-induced cough
Abstract
Background and aims: Bronchial provocation tests may be utilised to monitor the efficacy of the corticosteroid treatment. Unfortunately, these measurements necessitate good patient cooperation during the spirometry. Coughing during such tests is related to the degree of the bronchoconstriction and occurs involuntarily, i.e. independent of patient cooperation. This study aimed to evaluate the utility of a hypertonic histamine challenge-induced cough in assessing the efficacy of inhaled corticosteroid treatment.
Methods: A total of 16 steroid-naïve asthmatics and 10 non-asthmatic, symptomatic controls received 800-microg beclomethasone (Beclomet Easyhaler(R), Orion Ltd., Orion Pharma, Helsinki, Finland) via powder inhaler per day for 8 weeks. Videoed inhalation challenge with hypertonic histamine solution was performed before and after the treatment. Symptom questionnaire was completed before both challenges. The airway responsiveness to hypertonic histamine was expressed as the cumulative number of coughs divided by the final histamine concentration administered [coughs/concentration ratio (CCR)] and as the provocative concentration of histamine to induce a 20% fall in FEV(1)(PC(20)).
Results: CCR [geometric mean; 95% confidence interval (CI)] of the asthmatic subjects decreased from 494 (209-1168) to 73.6 (29.8-182) coughs per mg/mL (P = 0.002). Their PC(20) levels were 1.31 (1.07-1.60) and 1.91 (1.33-2.74) mg/mL over the treatment period (P = 0.01). The symptom frequency also decreased significantly in the asthmatics (P = 0.039). There were no significant changes in PC(20) level, in CCR level or in symptom frequency in non-asthmatic subjects during the treatment.
Conclusions: Hypertonic histamine challenge-induced cough and PC(20) are sensitive measures in assessing the treatment effect in asthma. The cough response may be especially useful in subjects who cannot perform spirometry reliably.
Similar articles
-
Cough-provocation tests with hypertonic aerosols.ERJ Open Res. 2020 Apr 19;6(2):00338-2019. doi: 10.1183/23120541.00338-2019. eCollection 2020 Apr. ERJ Open Res. 2020. PMID: 32337214 Free PMC article. Review.
-
Utility of cough response during hypertonic histamine challenge in diagnosing asthma.Respir Med. 2008 Oct;102(10):1379-84. doi: 10.1016/j.rmed.2008.05.006. Epub 2008 Jul 18. Respir Med. 2008. PMID: 18640018
-
Interpretation of cough provoked by airway challenges.Chest. 2005 Nov;128(5):3329-35. doi: 10.1378/chest.128.5.3329. Chest. 2005. PMID: 16304280 Clinical Trial.
-
Hypertonicity of the challenge solution may increase the diagnostic accuracy of histamine challenge.Respir Med. 2005 Jun;99(6):726-34. doi: 10.1016/j.rmed.2004.10.019. Epub 2004 Nov 25. Respir Med. 2005. PMID: 15878489
-
Methods for "indirect" challenge tests including exercise, eucapnic voluntary hyperpnea, and hypertonic aerosols.Clin Rev Allergy Immunol. 2003 Feb;24(1):27-54. doi: 10.1385/CRIAI:24:1:27. Clin Rev Allergy Immunol. 2003. PMID: 12644717 Review.
Cited by
-
Cough-provocation tests with hypertonic aerosols.ERJ Open Res. 2020 Apr 19;6(2):00338-2019. doi: 10.1183/23120541.00338-2019. eCollection 2020 Apr. ERJ Open Res. 2020. PMID: 32337214 Free PMC article. Review.
-
Cough response to isocapnic hyperpnoea of dry air and hypertonic saline are interrelated.Cough. 2011 Oct 14;7(1):8. doi: 10.1186/1745-9974-7-8. Cough. 2011. PMID: 21999754 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical